Purpose/ Objective

Cardiovascular magnetic resonance imaging has unique capabilities in assessing cardiac anatomic structure, function, ischemia, and infarction.  The lack of ionizing radiation and lack of use of iodinated contrast media also has increased the utilization of CMR as a desirable advanced imaging modality. This will help cardiovascular professionals in the usage, performance, and utilization of CMR in the area of ischemic heart disease. Following this session, learners will be better prepared to understand and provide CMR assessment for the referring question of interest - i.e. presence/absence of ischemia, presence/absence/degree of myocardial viability and provide CMR assessment in structure and function to assist in optimal medical management of ischemic heart disease.

Accreditation Statement

The Society for Cardiovascular Magnetic Resonance (SCMR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Society for Cardiovascular Magnetic Resonance (SCMR) designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions for Claiming CME

• Attend the sessions in full for which credit is sought
• Complete the post-activity evaluation
• A certificate of completion will be available once the evaluation is submitted

Financial Disclosures

The planners and faculty for this activity did not have any relevant relationships to disclose, unless listed below:
Dr. Bucciarelli-Ducci has received consulting fees and/or honoraria from Circle Cardiovascular Imaging, Inc. She also is an expert witness for Brachers, LLP.
Dr. Berry has received consulting fees and/or honoraria from AstraZeneca and from St. Jude Medical Center.

Any resulting conflicts of interest were resolved prior to the start of the activity according to ACCME Criteria & Standards.

Disclosure of Commercial Support

SCMR received no funding to support this activity.

Bibliography

1. Bejan, GC, Ceck, CD. Modern risk stratification in coronary artery disease. Journal of Medicine and Life. 2011: Vol 4 (4):377-386.
2. Aye, T and Graham, R. Risk stratification in stable coronary artery disease. Continuing Cardiology Education. 2017;3(1).
3. Ragupathi, L and Pavri, BB. Tools for risk stratification of sudden cardiac death: a review of the literature in different patient populations.  Indian Health Journal. 2014:66:571-581.
4. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)  European Heart Journal, Volume 35, Issue 37, 1 October 2014, Pages 2541–2619.
5. 2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology European Heart Journal, Volume 35, Issue 33, 1 September 2014, Pages 2260–2261.
6. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti ,O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000 Nov 16;343(20):1445–53. [PubMed]
7. Kim, HW, Rehwald, WG, Wendell, DC, Jenista, ER, van Assche, L, Jensen, CJ, Chen, E, Parker, MA, and Kim, RJ.  Flow-Independent Dark-blood DeLayed Enhancement (FIDDLE): validation of a novel black blood technique for the diagnosis of myocardial infarction. JCMR 2016: 18(Suppl 1):O55.
8. Kim, HW, Rehwald, WG, Jenista, ER, Wendell, DC, Filev, P, van Assche, L, Jensen, CJ, Parker, MA, Chen, E, Crowley, ALC, Klem, I, Judd, RM, and Kim, RJ.  Dark-Blood enhancement cardiac magnetic resonance of myocardial infarction.  JACC CV Imaging. 2017. In press, available online 13 Dec 2017.
9. Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. New Engl J Med. 2011 Apr 28;364(17):1607–16.
10. Lockie, T, Nagel, E, Redwood, S, and Plein, S. Use of cardiovascular magnetic resonance imaging in acute coronary syndromes. Circulation. 2009; 119:1671-1681.
11. Klem, I, Heitner, JF, Shah, DJ, Sketch, MH, Behar, V, Weinsaft, J, Cawley, P, Parker, M, Elliott, M, Judd, RM, and Kim, RJ.  Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. JACC 2006;47:1630-8.
12. Salerno, M, Kramer, CM. Advances in parametric mapping with CMR imaging. JACC CV Imaging 2013:6(7):806-22.
13. Messroghli, DR, Moon, JC, Ferreira, VM, Grosse-Wortmann, L, He, T, Kellman, P, Mascherbauer, J, Nezafat, R, Salerno, M, Schelbert, EB, Taylor, AJ, Thompson, R, Ugander, M, van Heeswijk, RB, and Friedrich, MG. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2*, and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI).  JCMR 2017;19:75.
14. Diamond, GA and Forrester, JS. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 1979; 300:1350-1358.
15. Motwani, M, MAredia, N, Fairbairn, TA, Kozerke, S, Greenwood, JP, and Plein, S. Assessment of ischaemic burden in angiographic three-vessel coronary artery disease with high-resolution cardiovascular magnetic resonance imaging.  European Heart J- CV Imaging. 2014:15(6);701-708.
16. Wellnhofer, E, Olariu, A, Klein, C, Grafe, M, Wahl, A, Fleck, E, and Nagel, E.  Magnetic resonance low-dose dobutamine test is superior to scar quantification for the prediction of functional recovery. Circulation. 2004:109:2172-2174.
17. Chotenimitkhun, R, and Hundley, WG. Pharmacologic Stress Cardiovascular Magnetic Resonance. Postgrad Med 2011 May 123(3):162-170.